Dr. Yanling Li

Assistant Professor
Wuhan University of Science and Technology, China


Highest Degree
M.D. in Internal Medicine from Shanghai Jiao Tong University, China

Share this Profile

Area of Interest:

Biomedical Sciences
Internal Medicine
Gastroenterology
Obstetrics
Cancer Biochemistry

Selected Publications

  1. Liu, Y., L. Xu, Q. Zeng, J. Wang and M. Wang et al., 2012. Downregulation of FGL 2/prothrombinase delays HCCLM 6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int., 32: 1585-1595.
    CrossRef  |  Direct Link  |  

  2. Wu, S., Y. Liu, L. Cheng, B. Yin, J. Peng and Z. Sun, 2011. Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China. J. Med. Virol., 83: 1930-1937.
    CrossRef  |  Direct Link  |  

  3. Liu, Y., S. Xu, F. Xiao, Y. Xiong and X. Wang et al., 2010. The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochem. Biophys. Res. Commun., 396: 555-561.
    CrossRef  |  Direct Link  |